Teichun Qin prioritizes sterility assurance in aseptic procedures and takes a meticulous approach to investigating any failures. He also insists on appropriate reporting and maintains a thorough focus on drug product labels and their adequacy.

FDA Investigator Teichun Qin is certainly an expert in the area of sterility assurance with an added focus on aseptic procedures and validation of sterilization processes. His attention to detail is evident from his historical scrutiny into container and closure sterility processing and aseptic processing area monitoring. In addition to that, he has shown an interest in tackling issues related to drug product batch testing, labels, and the control over labelling processes. Compliance with rules and regulations concerning the submission of reports is another area Qin takes very seriously.